In less than six years, Amneal Pharmaceuticals has become the seventh largest generic pharmaceutical manufacturer in the U.S. We’ve been recognized with awards, seen 109 million of our prescription drugs dispensed per year, built our infrastructure to an 18+ billion oral solid capacity and have nearly 240 ANDAs filed and/or in development. Despite this phenomenal growth, our focus on quality, superb service levels, and building strong relationships hasn’t wavered.
Now, we’re extending that philosophy further to the institutional market with the creation of Amneal Institutional—our specialized business unit focused on health systems and physicians/clinics. Areas of focus cover the acute care market, outpatient surgical and radiology services, specialty/oncology distributors, group purchasing organizations, wholesalers, home infusion service providers, and long-term care facilities. With a distinct product selection that includes specialty injectables (prefilled syringes, single dose vials, pharmacy bulk packaging, and premix bags) and unit-dose packaging, we’re now better poised to fill the unique needs of these markets. This new breadth of product joins the same proven bulk oral solids, topicals, and large-quantity oral liquid medications on which the Amneal reputation was built offering institutional pharmacies a broader selection of superb-quality generics.
Our dedicated and committed account management team boasts extensive experience from a variety of injectable manufacturers. This highly focused sales leadership group—together with the Amneal collaborative, transparent and responsive way of doing business—promises to deliver industry-recognized customer focus bolstered by unrelenting quality, development of non-price value, and a consistent supply of essential products to meet your needs and help improve the health of your patient.
Contact us to learn more about how we can do business together.